Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (2291) Stock Price & Analysis

1 Followers

2291 Stock Chart & Stats

HK$14.06-HK$0.94(-6.27%)
At close: 4:00 PM GMT+8
HK$12.5HK$15Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 13.90 - HKD 14.80
52-Week Range
HKD 8.33 - HKD 19.49
Previous Close
HKD 15.00
Volume
N/A
Average Volume (3M)
247.07K
Market Cap
HKD 5.13B
Enterprise Value
HKD 2.04B
Total Cash (Recent Filing)
HKD 1.29B
Total Debt (Recent Filing)
HKD 1.40M
Price to Earnings (P/E)
20.3
Beta
0.75
Next Earnings
Mar 26, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
May 27, 2026
Dividend Yield
4.07%

Bulls Say, Bears Say

Bulls Say

High Profitability

Very high gross, operating, and net margins indicate strong earnings power and potentially differentiated economics. If maintained, this profitability can support internal reinvestment, resilience during weaker demand, and continued value creation without requiring aggressive balance-sheet expansion.

Conservative Balance Sheet

Minimal leverage materially reduces financial risk and preserves flexibility for investment, research, or shareholder returns. A sizable and generally growing asset base provides additional resilience, while low debt limits interest burdens and refinancing pressure over the next several quarters.

Improving Cash Generation

Positive operating cash flow and improving free cash flow indicate that recent reported profitability is increasingly translating into funds available for reinvestment or distributions. The 2023–2025 improvement strengthens financial self-funding capacity and supports durability of the business model.

Bears Say

2025 Revenue Decline

The 2025 revenue contraction interrupts the company’s prior expansion and raises concern about near-term demand, market penetration, or product momentum. Sustained weakness would reduce operating leverage and make it harder for the company to preserve its currently strong profitability profile.

Earnings Volatility

A prior net loss demonstrates that earnings are not uniformly stable across operating conditions. Although profitability has rebounded strongly, this history increases uncertainty around the persistence of current margins and suggests results could remain sensitive to changes in business performance.

Inconsistent Cash Conversion

Free cash flow that regularly trails net income indicates that accounting profits do not always convert fully into discretionary cash. Periodic cash pressure can constrain reinvestment and distributions, while the 2022 deficit highlights potential variability in funding capacity.

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H News

2291 FAQ

What was LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s price range in the past 12 months?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H lowest stock price was HK$8.33 and its highest was HK$19.49 in the past 12 months.
What is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s market cap?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s market cap is HK$5.13B.
When is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s earnings last quarter?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H released its earnings results on Aug 21, 2026. The company reported HK$0.494 earnings per share for the quarter.
Is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pay dividends?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pays an annual dividend of HK$0.573 which represents an annual dividend yield of 4.07%. See more information on LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H dividends here
What is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s EPS estimate?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H have?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has 341,776,000 shares outstanding.
What happened to LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s price movement after its last earnings report?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H reported an EPS of HK$0.494 in its last earnings report. Following the earnings report the stock price went up 20.525%.
Which hedge fund is a major shareholder of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2291
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology